Sigilon Therapeutics
Latest round
- Series B
Last raised
- Mar 2020
Total raised
- $80M
Investors
- 5
About Sigilon Therapeutics
Sigilon Therapeutics, Inc.Founded in 2015 in Cambridge, US, Sigilon Therapeutics, Inc. specializes in cell therapy development. The co-founders, Daniel Anderson and Omid Veiseh, have backgrounds in biotechnology, contributing to the company's strategic direction and innovations.Sigilon Therapeutics, Inc. develops advanced cell therapies designed to treat chronic diseases and genetic disorders.In 2022, Sigilon Therapeutics, Inc.Following its acquisition in June 2023 by Eli Lilly and Company, Sigilon Therapeutics, Inc. The company aims to introduce new products targeting chronic and genetic diseases, with specific plans to enter additional markets in North America and Europe by the end of 2024. This strategic focus is part of their broader goal to enhance therapeutic options available to patients.
Who invested in Sigilon Therapeutics
5 investors across 1 round
See all investors in Sigilon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 17, 2020
Amount
$80M
Investors
Questions about Sigilon Therapeutics
Who invested in Sigilon Therapeutics?
Sigilon Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sigilon Therapeutics raised?
Sigilon Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sigilon Therapeutics last raise money?
Sigilon Therapeutics's most recent round on record is a Series B, in Mar 2020.
What does Sigilon Therapeutics do?
Sigilon Therapeutics is a pharmaceuticals company.
Where is Sigilon Therapeutics headquartered?
Sigilon Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Sigilon Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Sigilon Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Sigilon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.